Potential genetic risk factors in angiotensin‐converting enzyme‐inhibitor‐induced angio‐oedema

Abstract

Our data suggest that polymorphism of ACE I/D and the bradykinin B2 receptor polymorphisms are not involved in the development of ACEi-induced angio-oedema when considered individually. Further studies should be carried out to clarify whether a combination of these polymorphisms might be a risk factor for ACEi-induced angio-oedema.